BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4151770)

  • 1. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
    Kulkarni AS
    Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
    [No Abstract]   [Full Text] [Related]  

  • 2. Piperacetazine and chlorpromazine: a comparison.
    Johnson AC; Kulkarni AS
    Am J Psychiatry; 1973 May; 130(5):603-5. PubMed ID: 4144711
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 4. Penfluridol: a long acting oral antipsychotic drug.
    Claghorn JL; Mathew RJ; Mirabi M
    J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 6. New drug offers hope for people with schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract]   [Full Text] [Related]  

  • 8. New antipsychotic medications: do research results relate to clinical practice?
    MacEwan GW
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenperone: a controlled evaluation in chronic schizophrenic patients.
    Mielke DH; Gallant DM; Kessler C; Roniger JJ
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):636-40. PubMed ID: 812640
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplified symptom registration in psychiatric trials: a statistical approach.
    Hansen V; Hagen AS; Lehmann EH; Astrup C
    Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
    [No Abstract]   [Full Text] [Related]  

  • 13. Piperacetazine study in state hospital patients.
    del Portillo L
    J Med Assoc Ga; 1974 Dec; 63(12):465-7. PubMed ID: 4154960
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of schizophrenia: a review.
    Sigmundson HK
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
    Ruiz-Navarro JF; Vergara L; Deutsch M
    Psychopharmacol Bull; 1976 Jan; 12(1):38-9. PubMed ID: 1108083
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical study of mesoridazine and chlorpromazine in relapsed schizophrenic patients.
    Bankier RG; Mathewson FA
    Dis Nerv Syst; 1972 Aug; 33(8):529-34. PubMed ID: 4567534
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential value of penfluridol and pipothiazine palmitate.
    Gallant DM
    Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
    Moore DF
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):172-80. PubMed ID: 809232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.